Page last updated: 2024-12-07

piperazine-n,n'-bis(2-ethanesulfonic acid)

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Piperazine-N,N'-bis(2-ethanesulfonic acid) (PIPES) is a zwitterionic buffer commonly used in biological research. It is synthesized by reacting piperazine with 2-chloroethanesulfonic acid. PIPES is a good buffer in the pH range of 6.1 to 7.5, making it suitable for many biochemical experiments involving enzymes, proteins, and other biological molecules. It is often used in cell culture media and in studies of protein folding and stability. PIPES is also used as a buffer in electrochemistry and chromatography. The compound is known for its high buffering capacity, low toxicity, and good solubility in water. It is a stable compound and does not readily react with other molecules, making it ideal for use in sensitive biological experiments. PIPES is widely studied due to its versatility and effectiveness in various biological applications.'

piperazine-N,N'-bis(2-ethanesulfonic acid): RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

2,2'-piperazine-1,4-diylbisethanesulfonic acid : A Good's buffer substance, pKa = 6.8 at 20 degreeC. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID79723
CHEBI ID44933
SCHEMBL ID63679
MeSH IDM0053186

Synonyms (55)

Synonym
g502h79v6l ,
unii-g502h79v6l
einecs 227-057-6
nsc 157117
PIPES ,
piperazine-n,n'-bis(2-ethanesulfonic acid)
5625-37-6
nsc-157117
1,4-piperazinebis(ethanesulfonic acid)
1,4-piperazinediethanesulfonic acid
nsc157117
pipes, >=99% (titration)
pipes, bioperformance certified, suitable for cell culture, >=99%
pipes, bioxtra, >=99% (titration)
2,2'-piperazine-1,4-diylbisethanesulfonic acid
2,2'-(piperazine-1,4-diyl)bis(ethanesulphonic) acid
2,2'-piperazine-1,4-diyldiethanesulfonic acid
CHEBI:44933
NCGC00164485-01
pipes, bioxtra, for molecular biology, >=99.5% (t)
2-[4-(2-sulfoethyl)piperazin-1-yl]ethanesulfonic acid
A830975
2,2'-(piperazine-1,4-diyl)diethanesulfonic acid
c8h18n2o6s2
piperazine-n,n-bis(2-ethanesulfonic acid)
FT-0635789
AKOS015902699
SCHEMBL63679
pipes [mi]
DTXSID8063965
W-105526
piperazine-1,4-bis-(2-ethanesulfonic acid)
piperazine-1,4-bisethanesulfonic acid
1,4-piperazinebis(ethanesulphonic acid)
mfcd00006159
2-[4-(2-sulfoethyl)piperazin-1-yl]ethane-1-sulfonic acid
pipes, vetec(tm) reagent grade, >=99%
pipes, anhydrous, free-flowing, redi-dri(tm), >=99%
SY018288
pipes; 1,4-piperazinediethanesulfonic acid
5-cyclopropyl-2-ethyl-2h-pyrazole-3-carboxylicacid
F20299
pipes, free acid
1,4-piperazine bis(ethanesulfonic acid)
AS-12650
Q7119420
AMY23365
1,4-piperazinediethanesulfonic acid;1,4-piperazine bis(ethanesulfonic acid);nsc 157117
piperazine-n
piperazine-n,n'-bis-(2-ethanesulphonic acid)
piperazine-n,n`-bis(2-ethanesulfonic acid)
2,2'-(piperazine-1,4-diyl)diethanesulfonicacid
2-[4-(2-sulfonatoethyl)piperazine-1,4-diium-1-yl]ethanesulfonate
CS-0015185
HY-D0875

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"The toxic effects of U(VI) were studied using Desulfovibrio desulfuricans G20 in a medium containing bicarbonate or 1,4-piperazinediethane sulfonic acid disodium salt monohydrate (PIPES) buffer (each at 30 mM and pH 7)."( Toxic effects of uranium on Desulfovibrio desulfuricans G20.
Dohnalkova, A; Peyton, BM; Sani, RK, 2006
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
PIPES
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (34)

TimeframeStudies, This Drug (%)All Drugs %
pre-199016 (47.06)18.7374
1990's8 (23.53)18.2507
2000's6 (17.65)29.6817
2010's4 (11.76)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.69

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.69 (24.57)
Research Supply Index3.64 (2.92)
Research Growth Index4.33 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.69)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other37 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]